Updated Jul 16, 2026
Young Alethia has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $6K.
Alethia Young is the Chief Financial Officer of Bicycle Therapeutics PLC, a clinical-stage biopharmaceutical company focused on developing innovative medicines for oncology. She has been involved in the company's financial operations and strategic planning.
| Role | Director |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-13 | PCRX | Pacira BioSciences, Inc. | A — Grant or award | 6.4K | $0.00 | |
| 2025-10-02 | BCYC | BICYCLE THERAPEUTICS PLC | S — Open-market sale | 265 | $8.61 | $2K |
| 2025-10-02 | BCYC | BICYCLE THERAPEUTICS PLC | S — Open-market sale | 217 | $8.40 | $2K |
| 2025-07-02 | BCYC | BICYCLE THERAPEUTICS PLC | S — Open-market sale | 204 | $7.09 | $1K |
Alethia Young is the Chief Financial Officer of Bicycle Therapeutics PLC, a clinical-stage biopharmaceutical company focused on developing innovative medicines for oncology. She has been involved in the company's financial operations and strategic planning.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($6K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Young Alethia profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.